Technologies
Should You Expect NeuroSense Therapeutics Ltd (NASDAQ:NRSN) To Recover From Its 78.02% Gain From Highs?
NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s traded shares stood at 0.11 million during the last session, with the company’s beta value hitting 1.55. At the close of
